Ignite Creation Date:
2025-12-25 @ 2:55 AM
Ignite Modification Date:
2026-05-01 @ 2:16 AM
Study NCT ID:
NCT04805333
Status:
COMPLETED
Last Update Posted:
2025-02-10
First Post:
2021-03-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Dose Escalation of ArtemiCoffee
Sponsor:
Frederick R. Ueland, M.D.
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MCC-20-GYN-08
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | UNKNOWN | View |